The oncoprotein TBX3 is controlling severity in experimental arthritis
Abstract Background Development of autoimmune diseases is the result of a complex interplay between hereditary and environmental factors, with multiple genes contributing to the pathogenesis in human disease and in experimental models for disease. The T-box protein 3 is a transcriptional repressor e...
Main Authors: | Samra Sardar, Alish Kerr, Daniëlle Vaartjes, Emilie Riis Moltved, Edita Karosiene, Ramneek Gupta, Åsa Andersson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-018-1797-3 |
Similar Items
-
Identification of TBX2 and TBX3 variants in patients with conotruncal heart defects by target sequencing
by: Huilin Xie, et al.
Published: (2018-09-01) -
TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma
by: Lin Cheng, et al.
Published: (2021-07-01) -
TBX6-associated Congenital Scoliosis: A New Congenital Scoliosis Subtype Defined by Chinese
by: WU Nan, et al.
Published: (2022-09-01) -
Abnormal expression of TBX4 during anorectal development in rat embryos with ethylenethiourea-induced anorectal malformations
by: Meng Li, et al.
Published: (2019-05-01) -
İzole TB delesyonu saptanan 22q11 delesyon sendromlu bir yenidoğan olgusu
by: Özden TURAN, et al.
Published: (2020-03-01)